全文获取类型
收费全文 | 567192篇 |
免费 | 28622篇 |
国内免费 | 3223篇 |
专业分类
耳鼻咽喉 | 7881篇 |
儿科学 | 15395篇 |
妇产科学 | 15825篇 |
基础医学 | 77465篇 |
口腔科学 | 17436篇 |
临床医学 | 44841篇 |
内科学 | 111849篇 |
皮肤病学 | 12984篇 |
神经病学 | 38334篇 |
特种医学 | 24364篇 |
外国民族医学 | 179篇 |
外科学 | 89018篇 |
综合类 | 11010篇 |
现状与发展 | 1篇 |
一般理论 | 65篇 |
预防医学 | 33400篇 |
眼科学 | 13622篇 |
药学 | 44098篇 |
3篇 | |
中国医学 | 2328篇 |
肿瘤学 | 38939篇 |
出版年
2018年 | 7916篇 |
2017年 | 7202篇 |
2016年 | 6585篇 |
2015年 | 8664篇 |
2014年 | 9793篇 |
2013年 | 10578篇 |
2012年 | 19430篇 |
2011年 | 14605篇 |
2010年 | 8233篇 |
2009年 | 9529篇 |
2008年 | 11305篇 |
2007年 | 12843篇 |
2006年 | 13021篇 |
2005年 | 20098篇 |
2004年 | 21102篇 |
2003年 | 16494篇 |
2002年 | 11451篇 |
2001年 | 32356篇 |
2000年 | 30379篇 |
1999年 | 29218篇 |
1998年 | 5641篇 |
1997年 | 4491篇 |
1996年 | 4165篇 |
1995年 | 3828篇 |
1994年 | 3427篇 |
1992年 | 22713篇 |
1991年 | 21747篇 |
1990年 | 21370篇 |
1989年 | 20765篇 |
1988年 | 18944篇 |
1987年 | 18204篇 |
1986年 | 16984篇 |
1985年 | 15506篇 |
1984年 | 10456篇 |
1983年 | 8469篇 |
1982年 | 3703篇 |
1979年 | 9271篇 |
1978年 | 5687篇 |
1977年 | 4738篇 |
1976年 | 3785篇 |
1975年 | 5089篇 |
1974年 | 6152篇 |
1973年 | 5586篇 |
1972年 | 5549篇 |
1971年 | 5489篇 |
1970年 | 5049篇 |
1969年 | 4993篇 |
1968年 | 4475篇 |
1967年 | 4079篇 |
1966年 | 3693篇 |
排序方式: 共有10000条查询结果,搜索用时 523 毫秒
141.
Analyzing and shaping human attentional networks. 总被引:12,自引:0,他引:12
In this paper we outline a conception of attentional networks arising from imaging studies as connections between activated brain areas carrying out localized mental operations. We consider both the areas of functional activation (nodes) and the structural (DTI) and functional connections (DCM) between them in real time (EEG, frequency analysis) as important tools in analyzing the network. The efficiency of network function involves the time course of activation of nodes and their connectivity to other areas of the network. We outline landmarks in the development of brain networks underlying executive attention from infancy and childhood. We use individual differences in network efficiency to examine genetic alleles that are related to performance. We consider how animal studies might be used to determine the genes that influence network development. Finally we indicate how training may aid in enhancing attentional networks. Our goal is to show the wide range of methods that can be used to suggest and analyze models of network function in the study of attention. 相似文献
142.
To examine the prevalence of Internet sex networking among men who have sex with men (MSM) in Hong Kong and risk behaviors associated with the behavior, a telephone survey of 15,230 Hong Kong Chinese men aged 18-60 was conducted. Of the 283 active MSM (having engaged in some MSM behaviors in the last 6 months) identified, 17.7% had networked for MSM partners via the Internet in the last 6 months. Younger age (odds ratio [OR] for age < or = 25 vs. age >25 = 4.67, 95% confidence interval [CI] = 2.35-9.28) and being an anal-sex MSM (OR = 4.72, 95% CI=2.36-9.44) were independent predictors of Internet sex networking. Being an Internet sex networker was associated with some risk behaviors such as having contracted a sexually transmitted disease (adjusted OR = 4.79, 95% CI = 1.34-17.11), having had > or = 3 MSM partners (adjusted OR = 4.74, 95% CI = 2.20-10.23), and having engaged in anal sex (adjusted OR = 3.95, 95% CI = 1.89-8.23). HIV prevention programs for MSM should thereby include Internet-based interventions. 相似文献
143.
M B?ttner J Christoffel G Rimoldi W Wuttke 《Experimental and clinical endocrinology & diabetes》2006,114(2):82-90
The lack of estrogen during menopause is associated with various symptoms including osteoporosis, cardiovascular diseases, and menopausal symptoms. For many years, conventional hormone replacement therapy has been successfully used to treat these conditions. However, in light of recent studies that draw attention to potential hazards of conventional HRT, various attempts were undertaken to search for alternatives of classical HRT. Phytoestrogens are supposed to ameliorate various discomforts associated with menopause. Resveratrol (RES) is present in red wine, grapes and peanuts and has been implicated in cardioprotection and prevention of adverse side effects observed after regular HRT. As the pituitary-thyroid axis is a target of estrogen action, we first assessed the effects of E2 administration on thyroid hormone stimulating hormone releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion from pituitary cell cultures in vitro. Our data reveal that E2 treatment augments the TRH-induced TSH secretion. We furthermore designed a long-term study of three months to assess the effects of subcutaneous and oral administration of 17beta-estradiol (E2), as well as the actions of RES on the pituitary-thyroid axis in ovariectomized (OVX) female rats. Our results demonstrate that serum levels of 1.0 and 8.1 microM RES lead to a significant increase in total serum triiodthyronine (T3) levels. OVX induces TSHbeta mRNA in the adenohypohysis and E2 treatment attenuates this effect. Treatment of rats with subcutaneous implants of E2 does not affect the pituitary-thyroid axis, whereas orally applied E2 benzoate (E2B) increases plasma TSH and total thyroxine (T4) in OVX rats. In all animals, we could not detect changes in thyroid morphology as assessed by hematoxylin-eosin (HE) and Perjod-Acid Schiff's (PAS) staining. 相似文献
144.
S. Vitko Z. Wlodarczyk L. Kyllönen Z. Czajkowski R. Margreiter L. Backman F. Perner P. Rigotti B. Jaques D. Abramowicz M. Kessler J. Sanchez-Plumed L. Rostaing R.S. Rodger D. Donati Y. Vanrenterghem 《American journal of transplantation》2006,6(3):531-538
Tacrolimus combined with mycophenolate mofetil (MMF) is an effective regimen in kidney transplantation. This study compared the efficacy of combining tacrolimus and two different dosages of sirolimus with an established tacrolimus-MMF regimen. Each day in addition to tacrolimus, 325 patients received 2 mg sirolimus (TAC-SRL2 mg), 325 patients received 0.5 mg sirolimus (TAC-SRL0.5 mg) and 327 patients 1 g MMF (TAC-MMF). The initial tacrolimus dose was 0.2 mg/kg/day. Sirolimus patients received loading doses of 6 or 1.5 mg, and daily doses of 2 or 0.5 mg thereafter. Steroid administration was identical for all groups. The incidence of biopsy-proven acute rejection was lower in the TAC-SRL2 mg group (15.7%) compared with the TAC-SRL0.5 mg (25.2%, p = 0.003) and the TAC-MMF groups (22.3%, p = 0.036). Six-month graft survival was 91.0% (TAC-SRL2 mg), 92.6% (TAC-SRL0.5 mg) and 92.4% (TAC-MMF); the respective values for patient survival were 98.1%, 97.8% and 97.9%. Thirty-four patients (10.5%), 19 patients (5.8%) and 16 patients (4.9%) in the TAC-SRL2 mg, TAC-SRL0.5 mg and TAC-MMF groups, respectively, discontinued the study because of adverse events. Hyperlipemia was reported more often in the TAC-SRL2 mg group (24.0%) compared with 19.4% (TAC-SRL0.5 mg) and 11.0% (TAC-MMF; p < 0.05). Combining 2 mg sirolimus/day with tacrolimus results in lower rates of acute rejection, but a higher incidence of adverse events. 相似文献
145.
146.
147.
148.
149.
150.
Yaprak Engin-Ustün Yusuf Ustün M Mutlu Meydanli Ay?e Kafkasli 《Gynecological endocrinology》2006,22(12):676-679
AIM: To compare the effects of 17beta-estradiol given intranasally (intranasal E2) and raloxifene on serum lipid profile and fibrinogen in hypercholesterolemic postmenopausal women. METHODS: The study population consisted of 46 women after menopause. The placebo group (n = 11) was given calcium, while the intervention groups were given intranasal E2 (Aerodiol; Servier, Chambray-les-Tours, France) (n = 16) or raloxifene (Evista; Lilly SA, Madrid, Spain) (n = 19). Blood lipids and fibrinogen were compared between groups at baseline and after 3 months of treatment. RESULTS: The group receiving intranasal E2 showed a significant decrease in triglyceride levels (p<0.05) and a marked increase in high-density lipoprotein cholesterol levels (p<0.05). No changes in lipid profile were observed in the raloxifene and placebo groups. Raloxifene caused a significant decrease in fibrinogen levels (p<0.05). CONCLUSION: Intranasal E2 exerts significant effects on lipid profile in hypercholesterolemic postmenopausal women. Raloxifene has a greater impact on fibrinogen than intranasal E2 application. 相似文献